US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Apr 18, 2025 (17 months ago)

Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations

What was recalled

Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited, NDC 68788-8685-03.

Recalling firm
Preferred Pharmaceuticals, Inc.
NDC code
68788-8685-03
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0391-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all